top of page
The Professional Network for Healthcare Experts
FDA approves Yesintek single-dose autoinjector for chronic inflammatory diseases
The supplemental approval introduces a new self-injection option for patients receiving Yesintek across its approved autoimmune indications without changing the medicine's existing therapeutic uses.
nuaxia
Aug 212 min read
FDA approves Lerochol autoinjector and updates indication for monthly PCSK9 therapy
The new device provides adults with hypercholesterolaemia with an additional self-administration option for once-monthly Lerochol alongside the existing pre-filled syringe.
nuaxia
Aug 192 min read
bottom of page